Life sciences firms owe it to themselves to capitalise on new global insights contained within the substantial new regulatory database systems they have had to build for compliance purposes, says Amplexor's David Gwyn.
Dr Campbell Rogers, chief medical officer at HeartFlow discusses how digital technologies can play a role in helping health services identify and treat coronary heart disease.
Suzanne Ward, senior director of medical strategy at Boston Scientific, examines supply chains in 2020 and why patients should be aware of what's really in the medicines they take.
Andreas Gross - global product manager of Inspection Technology at Syntegon Technology, explains how artificial intelligence (AI) is being used to ensure pharmaceutical products are safe.
In this 'Women in Pharma' series, Barbara Morgan discusses key themes around women in the industry and offers advice for aspiring female leaders and their wider teams.
Bart Vansteenkiste, life science sector manager, Domino Printing Sciences, outlines how pharmaceutical companies can improve validation processes to improve their overall compliance.
EPM speaks to Nigel Theobald, CEO of N4 Pharma who discusses the formulation challenges that can occur during drug development and what the company is doing to improve vaccine delivery systems.
Dr Steven Fox, CEO and chairman of biopharmaceutical company Akelos speaks to EPM about how his company wants to tackle the opioid epidemic through the development of non-addictive drugs.
